BridgeBio Oncology Therapeutics (BBOT) vs BioAge Labs (BIOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
BioAge Labs (BIOA) has outperformed BridgeBio Oncology Therapeutics (BBOT) over the past year, gaining 11.8% versus a loss of 71.8%. BioAge Labs is the larger company by market cap ($287.3 million vs $275.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBOT | BIOA |
|---|---|---|
| Share price | $3.44 | $6.26 |
| Market cap | $275.80M | $287.31M |
| 1-day change | -1.71% | -0.48% |
| YTD return | -72.52% | -52.68% |
| 1-year return | -71.83% | +11.79% |
| EPS (TTM) | $-0.07 | $-2.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.87 | $25.96 |
| 52-week low | $3.36 | $5.04 |
| Distance from 52-week high | -76.87% | -75.88% |
| Average volume | 475.11K | 911.49K |
| Shares outstanding | 80.17M | 45.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BIOA has outperformed BBOT by 83.6 percentage points over the past year.
BBOT vs BIOA FAQ
Which is bigger, BridgeBio Oncology Therapeutics or BioAge Labs?
BioAge Labs (BIOA) is larger, with a market capitalization of $287.31M compared with $275.80M for BridgeBio Oncology Therapeutics (BBOT).
Which stock has performed better over the past year, BBOT or BIOA?
BIOA returned +11.79% over the past 12 months, compared with -71.83% for BBOT (price return, excluding dividends). Past performance does not predict future results.
Are BridgeBio Oncology Therapeutics and BioAge Labs in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.